Astellas Pharma Inks Licensing Deal with Sangamo Therapeutics for Neurological AV Capsid STAC-BBB
Japan-based Astellas Pharma Inc. (TYO: 4503) has revealed a strategic licensing agreement with US-based Sangamo...
BioArctic AB Secures Global Rights to PyroGlu-Aβ Antibody Program in BMS Deal
Sweden-based BioArctic AB (OTCMKTS: BRCTF) has announced a significant licensing agreement with US pharmaceutical giant...
Fangzhou Inc. Partners with BMS to Innovate Digital Medicine Platform
China-based Internet healthcare solutions provider Fangzhou Inc. (HKG: 6086) has entered into a partnership with...
Sanofi and Corxel Pharmaceuticals Partner for Aficamten in Greater China Rights
Global healthcare leader Sanofi (NASDAQ: SNY) and China-based Corxel Pharmaceuticals (CORXEL), formerly known as Ji...
HOB Biotech Group Corp. Acquired by Sino Biopharmaceutical Ltd for IVD Synergies
China-based in vitro diagnostic (IVD) reagents specialist HOB Biotech Group Corp., Ltd (SHA: 688656) has...
Joincare Pharmaceutical’s JKN2403 Gains NMPA Approval for COPD Clinical Trials
China-based Jo2006incare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) is set to advance its Category...
Sino Biopharmaceutical Ltd. Files for Benmelstobart and Anlotinib Combination Therapy in ASPS Treatment
China-based Sino Biopharmaceutical Ltd (HKG: 1177) is poised to make another indication approval filing with...
HighTide Therapeutics and SSY Group Ltd Join Forces to Tackle Metabolic and Aging Diseases
China-based HighTide Therapeutics Inc. (HKG: 2511) has announced a strategic collaboration framework agreement with compatriot...
AIM Vaccine Co., Ltd Receives NMPA Clearance for Innovative Cell-Based Influenza Vaccine
AIM Vaccine Co., Ltd (HKG: 6660), a China-based biopharmaceutical company, has announced that it has...
Henlius Biotech Expands Partnership with Palleon Pharmaceuticals for Autoimmune Disease Treatment
Shanghai Henlius Biotech Inc. (HKG: 2696), a leading biotechnology company based in China, has announced...
AIM Vaccine Co., Ltd Receives NMPA Approval for Second-Gen Tetanus Vaccine Clinical Trial
China-based AIM Vaccine Co., Ltd (HKG: 6660) has announced that it has received clinical trial...
MSD’s Clesrovimab for Infant RSV Protection: FDA Accepts BLA for Review
Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced that the U.S. Food and Drug...
Photys Therapeutics and Novo Nordisk Partner to Develop Proximity-Based Therapies for Cardiometabolic Diseases
US-based Photys Therapeutics, Inc. has entered into an agreement with Denmark-based Novo Nordisk A/S (NYSE:...
Merck to Acquire HUB Organoids Holding B.V., Advancing Organoid Technology in Drug Development
Merck (NYSE: MRK) has announced a definitive agreement with the intention to acquire HUB Organoids...
BioAge Labs and Novartis Partner to Discover Aging-Related Therapeutic Targets
US-based BioAge Labs, Inc. has announced a strategic research partnership with Swiss pharmaceutical giant Novartis...
DaAn Gene Co., Ltd Receives NMPA Approval for Genetic Deafness Gene Detection Kit
China-based DaAn Gene Co., Ltd, (SHE: 002030) affiliated with Sun Yat-sen University, has announced that...
MediLink Therapeutics’ YL201 Receives FDA Orphan Drug Designation for Small-Cell Lung Cancer
Suzhou-based biotech company MediLink Therapeutics (Suzhou) Co., Ltd has announced that the US Food and...
BMS Regains Exclusive Rights to ABZ-706 in Greater China
Bristol-Myers Squibb (BMS; NYSE: BMY) has reached an agreement with China-based Ablaze Pharmaceuticals to regain...
Everest Medicines’ Nefecon Receives First Prescription for IgAN Treatment in Adults
China-based Everest Medicines (HKG: 1952) has announced that its targeted-release budesonide, Nefecon, has been prescribed...
FDA Approves Xcovery Holdings’ Ensartinib for Untreated ALK-Positive NSCLC Patients
On December 18, 2024, the Food and Drug Administration (FDA) granted approval for Betta Pharmaceutical...